Olivia Newton-John Cancer Wellness and Research Centre

OrgUnit's Researchers
(Persons)

Results 1-5 of 45 (Search time: 0.002 seconds).

FullnameTranslated NameEmail
Berlangieri, AlexandraAlexandra.BERLANGIERI@austin.org.au
Berlangieri, Salvatore USam.Berlangieri@austin.org.au
Berry, ColleenColleen.BERRY@austin.org.au
Brown, KerrynKez.Brown@austin.org.au
Burgess, Adele NAdele.BURGESS@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 201-220 of 927 (Search time: 0.01 seconds).

Publication YearTitleAuthor(s)
2012-Dec-2021Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273].Reck, M; Ciuleanu, T-E; Cobo, M; Schenker, M; Zurawski, B; Menezes, J; Richardet, E; Bennouna, J; Felip, E; Juan-Vidal, O; Alexandru, A; Sakai, H; Lingua, A; Reyes, F; Souquet, P-J; De Marchi, P; Martin, C; Pérol, M; Scherpereel, A; Lu, S; Paz-Ares, L; Carbone, D P; Memaj, A; Marimuthu, S; Zhang, X; Tran, P; John, Thomas 
2028-Nov-2013The cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: results from the Australasian phase III MAX study.Carter, Hannah E; Zannino, Diana; John Simes, R; Schofield, Deborah J; Howard, Kirsten; Zalcberg, John R; Price, Timothy J; Tebbutt, Niall C 
203May-2017Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: an early decision analytic model of multiplex targeted sequencing.Doble, Brett; John, Thomas ; Thomas, David; Fellowes, Andrew; Fox, Stephen; Lorgelly, Paula
20430-Jun-2021COVID-19, Alcohol Consumption and Stockpiling Practises in Midlife Women: Repeat Surveys During Lockdown in Australia and the United Kingdom.Miller, Emma R; Olver, Ian N; Wilson, Carlene J ; Lunnay, Belinda; Meyer, Samantha B; Foley, Kristen; Thomas, Jessica A; Toson, Barbara; Ward, Paul R
20516-Mar-2020Credentialing of vertebral stereotactic ablative body radiotherapy in a multi-centre trial.Hardcastle, Nicholas; Kron, Tomas; Cook, Olivia; Lehmann, Joerg; Mitchell, Paul L R ; Siva, Shankar
20629-Jul-2022A critical evaluation of the role of iron overload in fatty liver disease.Fernandez, Monique; Lokan, Julie ; Leung, Christopher ; Grigg, Andrew P 
20726-Feb-2014A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma.Do, Hongdo; Wong, Nicholas C; Murone, Carmel ; John, Thomas ; Solomon, Benjamin J; Mitchell, Paul L R ; Dobrovic, Alexander 
2085-Oct-2021Curative Radiotherapy for Locally Advanced Scalp Squamous Cell Carcinoma.Xing, Daniel T ; Hettige, Supan; Chee, Lessandra Yan Shan; Nair, Rohan; Hegde, Rajendra
20931-May-2016Current and evolving methods to visualize biological data in cancer researchChia, Puey Ling ; Gedye, Craig; Boutros, Paul C; Wheatley-Price, Paul; John, Thomas 
2102020Current Development of Monoclonal Antibodies in Cancer Therapy.Parakh, Sagun ; King, Dylan ; Gan, Hui K ; Scott, Andrew M 
2112022Current State of Neoadjuvant Radiotherapy for Rectal Cancer.Ng, Sweet Ping ; Ngan, Samuel Y; Leong, Trevor
21219-Sep-2019Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma.Ratnasingam, Sumita; Casan, Joshua; Shortt, Jake; Hawkes, Eliza A ; Gilbertson, Michael; McQuilten, Zoe; Grigoriadis, George; Htun, Kay Thwe; Htet, Swe Myo; Campbell, Philip; Chai, Khai Li; Quach, Hang; Patil, Sushrut; Opat, Stephen
21321-Jul-2018Dapsone safety in haematology patients: pathways to optimising Pneumocystis jirovecii pneumonia prophylaxis in haematology malignancy and transplant recipients.Urbancic, Karen F ; Pisasale, D ; Wight, Joel C ; Trubiano, Jason 
214Sep-2019DDR Alterations as a Surrogate Marker for TMB in SCLC - Use it or Lose it?Arulananda, Surein; Mitchell, Paul L R ; John, Thomas 
215Sep-2017De novo activating epidermal growth factor mutations (EGFR) in small-cell lung cancer.Thai, Alesha; Chia, Puey L; Russell, Prudence A; Do, Hongdo; Dobrovic, Alexander ; Mitchell, Paul L R ; John, Thomas 
21630-Oct-2023Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United Kingdom.Minson, Adrian; Hamad, Nada; Di Ciaccio, Pietro; Talaulikar, Dipti; Ku, Matthew; Ratnasingam, Sumita; Cheah, Chan; Yannakou, Costas K; Bishton, Mark; Ng, Zi Yun; Agrawal, Shivam; McQuillan, Andrew; Johnston, Anna; Choong, Emily; Wong, Kimberly; McQuillan, James; Beekman, Ashley; Hawkes, Eliza A ; Dickinson, Michael
217Jun-2021A deep-learning system for the assessment of cardiovascular disease risk via the measurement of retinal-vessel calibre.Cheung, Carol Y; Xu, Dejiang; Cheng, Ching-Yu; Sabanayagam, Charumathi; Tham, Yih-Chung; Yu, Marco; Rim, Tyler Hyungtaek; Chai, Chew Yian; Gopinath, Bamini; Mitchell, Paul L R ; Poulton, Richie; Moffitt, Terrie E; Caspi, Avshalom; Yam, Jason C; Tham, Clement C; Jonas, Jost B; Wang, Ya Xing; Song, Su Jeong; Burrell, Louise M ; Farouque, Omar ; Li, Ling Jun; Tan, Gavin; Ting, Daniel S W; Hsu, Wynne; Lee, Mong Li; Wong, Tien Y
218Nov-2023Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study-TROG 18.06.Barry, Nathaniel; Francis, Roslyn J; Ebert, Martin A; Koh, Eng-Siew; Rowshanfarzad, Pejman; Hassan, Ghulam Mubashar; Kendrick, Jake; Gan, Hui K ; Lee, Sze Ting ; Lau, Eddie ; Moffat, Bradford A; Fitt, Greg ; Moore, Alisha; Thomas, Paul; Pattison, David A; Akhurst, Tim; Alipour, Ramin; Thomas, Elizabeth L; Hsiao, Edward; Schembri, Geoffrey P; Lin, Peter; Ly, Tam; Yap, June; Kirkwood, Ian; Vallat, Wilson; Khan, Shahroz; Krishna, Dayanethee; Ngai, Stanley; Yu, Chris; Beuzeville, Scott; Yeow, Tow C; Bailey, Dale; Cook, Olivia; Whitehead, Angela; Dykyj, Rachael; Rossi, Alana; Grose, Andrew; Scott, Andrew M 
2192023Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial.Lassman, Andrew B; Pugh, Stephanie L; Wang, Tony J C; Aldape, Kenneth; Gan, Hui K ; Preusser, Matthias; Vogelbaum, Michael A; Sulman, Erik P; Won, Minhee; Zhang, Peixin; Moazami, Golnaz; Macsai, Marian S; Gilbert, Mark R; Bain, Earle E; Blot, Vincent; Ansell, Peter J; Samanta, Suvajit; Kundu, Madan G; Armstrong, Terri S; Wefel, Jeffrey S; Seidel, Clemens; de Vos, Filip Y; Hsu, Sigmund; Cardona, Andrés F; Lombardi, Giuseppe; Bentsion, Dmitry; Peterson, Richard A; Gedye, Craig; Bourg, Véronique; Wick, Antje; Curran, Walter J; Mehta, Minesh P
2201-Jun-2004Detection of occult bone metastases of lung cancer with fluorine-18 fluorodeoxyglucose positron emission tomography.Foo, Serene S; Ramdave, Shankar; Berlangieri, Salvatore U ; Scott, Andrew M